Using chromosome rearrangements as tumour-specific markers for disease monitoring in lung cancer using droplet digital PCR [ 2018 - 2022 ]

Research Grant

Researchers: A/Pr Alexander Dobrovic (Principal investigator) ,  A/Pr Gavin Wright ,  A/Pr Paul Mitchell ,  A/Pr Thomas John ,  Prof Benjamin Solomon

Brief description There are no useful markers apart from CT scans to determine the effectiveness of therapy in patients with lung cancer. We plan to assess highly sensitive methods that can examine the blood to determine whether DNA from the patient’s tumour is present. This will allow more responsive modulation of therapy to enable better management of the cancer.

Funding Amount $AUD 1,096,473.48

Funding Scheme Project Grants

Notes Standard Project Grant